Theranostic nanomedicine for cancer detection and treatment

Cancer is the second leading cause of death in the USA according to the American Cancer Society. In the past 5 years, “theranostic nanomedicine”, for both therapeutics and imaging, has shown to be “the right drug for the right patient at the right moment” to manage deadly cancers. This review articl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhen, Fu, Peter P., Yu, Hongtao, Ray, Paresh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359153/
https://www.ncbi.nlm.nih.gov/pubmed/24673900
http://dx.doi.org/10.1016/j.jfda.2014.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359153/
https://www.ncbi.nlm.nih.gov/pubmed/24673900
http://dx.doi.org/10.1016/j.jfda.2014.01.001

Ejemplares similares